Technicals - Good breakout on increasing volume - early days, page-146

First 146 Last

Share
Profile

Follow
jscopas

1,268 Posts.

67

21/11/19

11:02

Post #: 41551006
Share
Originally posted by AusDoc88: ↑

See below for the great article for this company.

disallowed link/investment-news/using-ai-to-assess-blood-samples/146402?v=999919

Plenty of good things to come in my opinion. From my experience working in the Australian Healthcare industry, both public and private sectors, any technology that: (1) reduces labour costs; (2) enhances efficiency; and (3) addresses work force shortages of specialised skills will be attractive to both medical directors and higher level administrators.

This company has had share-price setbacks and in my opinion the market has punished the company for delayed outcomes and timeline missteps - compounded by poor communication.

Ultimately I think:
The technology they have invested in for many year is excellent
They have thought well about how to generate long-term revenue in a caped market
They have developed relationships in European, Australian and American test-centres appropriately, with lab directors who are interested in promoting the importance of technological development
They have cleared CE and FDA regulatory hurdles for de novo products; and,
They are are now securing the appropriate distributions partnerships

LBT Innovations will be a great A.I. Australian Biotechnology company that history will ultimately look kindly upon.

AIMHO DYOR

Expand

selle s or gone ,has reached rock bottom imo..now for an update to see this company fly.
LBT Price at posting: 17.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

SGP

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

RAD

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

PAM

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

First 146 Last

Add LBT (ASX) to my watchlist

(20min delay)
Last 2.0¢		Change 0.002(11.1%)		Mkt cap ! $35.16M

Open	High	Low	Value	Volume
1.9¢	2.0¢	1.7¢	$44.06K	2.412M

Buyers (Bids)

No.	Vol.	Price($)
2	821520	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	319293	2

View Market Depth

No.	Vol.	Price($)
2	821520	0.018
5	1706996	0.017
11	4110000	0.016
5	883664	0.015
7	1228571	0.014

Price($)	Vol.	No.
0.020	319293	2
0.021	319551	2
0.023	558882	2
0.024	200000	1
0.025	522580	2

Last trade - 16.10pm 19/11/2024 (20 minute delay)

LBT (ASX) Chart

Technicals - Good breakout on increasing volume - early days, page-146

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Technicals - Good breakout on increasing volume - early days, page-146

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News